ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 255 filers reported holding ICU MED INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,500 | +55.9% | 21 | +133.3% | 0.00% | – |
| Q2 2023 | $1,604 | +21.5% | 9 | +12.5% | 0.00% | – |
| Q1 2023 | $1,320 | +4.8% | 8 | 0.0% | 0.00% | – |
| Q4 2022 | $1,260 | -37.0% | 8 | -20.0% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 10 | +11.1% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 9 | -10.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 10 | +25.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 8 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 8 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 8 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 8 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 8 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -92.3% | 8 | -88.9% | 0.00% | – |
| Q2 2020 | $13,000 | -13.3% | 72 | -2.7% | 0.00% | – |
| Q1 2020 | $15,000 | +650.0% | 74 | +640.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 10 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | +50.0% | 10 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 10 | +25.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 8 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 8 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 8 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |